111 related articles for article (PubMed ID: 7515064)
1. Localization of functionally important epitopes within the second C-type domain of coagulation factor V using recombinant chimeras.
Ortel TL; Quinn-Allen MA; Keller FG; Peterson JA; Larocca D; Kane WH
J Biol Chem; 1994 Jun; 269(22):15898-905. PubMed ID: 7515064
[TBL] [Abstract][Full Text] [Related]
2. Deletion analysis of recombinant human factor V. Evidence for a phosphatidylserine binding site in the second C-type domain.
Ortel TL; Devore-Carter D; Quinn-Allen M; Kane WH
J Biol Chem; 1992 Feb; 267(6):4189-98. PubMed ID: 1740460
[TBL] [Abstract][Full Text] [Related]
3. Binding of factor VIII inhibitors to discrete regions of the factor VIII C2 domain disrupt phospholipid binding.
Lewis DA; Moore KD; Ortel TL
Blood Coagul Fibrinolysis; 2003 Jun; 14(4):361-8. PubMed ID: 12945878
[TBL] [Abstract][Full Text] [Related]
4. Characterization of an acquired inhibitor to coagulation factor V. Antibody binding to the second C-type domain of factor V inhibits the binding of factor V to phosphatidylserine and neutralizes procoagulant activity.
Ortel TL; Quinn-Allen MA; Charles LA; Devore-Carter D; Kane WH
J Clin Invest; 1992 Dec; 90(6):2340-7. PubMed ID: 1281831
[TBL] [Abstract][Full Text] [Related]
5. Role of the B domain for factor VIII and factor V expression and function.
Pittman DD; Marquette KA; Kaufman RJ
Blood; 1994 Dec; 84(12):4214-25. PubMed ID: 7994036
[TBL] [Abstract][Full Text] [Related]
6. Identification of functionally important amino acid residues within the C2-domain of human factor V using alanine-scanning mutagenesis.
Kim SW; Quinn-Allen MA; Camp JT; Macedo-Ribeiro S; Fuentes-Prior P; Bode W; Kane WH
Biochemistry; 2000 Feb; 39(8):1951-8. PubMed ID: 10684644
[TBL] [Abstract][Full Text] [Related]
7. Identification of the MMRN1 binding region within the C2 domain of human factor V.
Jeimy SB; Woram RA; Fuller N; Quinn-Allen MA; Nicolaes GA; Dahlbäck B; Kane WH; Hayward CP
J Biol Chem; 2004 Dec; 279(49):51466-71. PubMed ID: 15452129
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory anti-factor V antibodies bind to the factor V C2 domain and are associated with hemorrhagic manifestations.
Ortel TL; Moore KD; Quinn-Allen MA; Okamura T; Sinclair AJ; Lazarchick J; Govindan R; Carmagnol F; Kane WH
Blood; 1998 Jun; 91(11):4188-96. PubMed ID: 9596666
[TBL] [Abstract][Full Text] [Related]
9. Effect of heterologous factor V heavy chain sequences on the secretion of recombinant human factor VIII.
Ortel TL; Moore KD; Ezban M; Kane WH
Thromb Haemost; 1996 Jan; 75(1):36-44. PubMed ID: 8713777
[TBL] [Abstract][Full Text] [Related]
10. Anti-factor V auto-antibody in the plasma and platelets of a patient with repeated gastrointestinal bleeding.
Ajzner E; Balogh I; Haramura G; Boda Z; Kalmár K; Pfliegler G; Dahlbäck B; Muszbek L
J Thromb Haemost; 2003 May; 1(5):943-9. PubMed ID: 12871359
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibodies against HIV type 1 integrase: clues to molecular structure.
Bizub-Bender D; Kulkosky J; Skalka AM
AIDS Res Hum Retroviruses; 1994 Sep; 10(9):1105-15. PubMed ID: 7530024
[TBL] [Abstract][Full Text] [Related]
12. A 110-amino acid region within the A1-domain of coagulation factor VIII inhibits secretion from mammalian cells.
Marquette KA; Pittman DD; Kaufman RJ
J Biol Chem; 1995 Apr; 270(17):10297-303. PubMed ID: 7730335
[TBL] [Abstract][Full Text] [Related]
13. Human factor VIII procoagulant protein. Monoclonal antibodies define precursor-product relationships and functional epitopes.
Fulcher CA; Roberts JR; Holland LZ; Zimmerman TS
J Clin Invest; 1985 Jul; 76(1):117-24. PubMed ID: 2410456
[TBL] [Abstract][Full Text] [Related]
14. Partial glycosylation at asparagine-2181 of the second C-type domain of human factor V modulates assembly of the prothrombinase complex.
Kim SW; Ortel TL; Quinn-Allen MA; Yoo L; Worfolk L; Zhai X; Lentz BR; Kane WH
Biochemistry; 1999 Aug; 38(35):11448-54. PubMed ID: 10471296
[TBL] [Abstract][Full Text] [Related]
15. Biosynthesis, assembly and secretion of coagulation factor VIII.
Kaufman RJ; Pipe SW; Tagliavacca L; Swaroop M; Moussalli M
Blood Coagul Fibrinolysis; 1997 Dec; 8 Suppl 2():S3-14. PubMed ID: 9607108
[TBL] [Abstract][Full Text] [Related]
16. Factor VIII C2 domain contains the thrombin-binding site responsible for thrombin-catalyzed cleavage at Arg1689.
Nogami K; Shima M; Hosokawa K; Nagata M; Koide T; Saenko EL; Tanaka I; Shibata M; Yoshioka A
J Biol Chem; 2000 Aug; 275(33):25774-80. PubMed ID: 10831589
[TBL] [Abstract][Full Text] [Related]
17. Fine mapping of inhibitory anti-factor V antibodies using factor V C2 domain mutants. Identification of two antigenic epitopes involved in phospholipid binding.
Izumi T; Kim SW; Greist A; Macedo-Ribeiro S; Fuentes-Prior P; Bode W; Kane WH; Ortel TL
Thromb Haemost; 2001 Jun; 85(6):1048-54. PubMed ID: 11434683
[TBL] [Abstract][Full Text] [Related]
18. Structural and functional studies with antibodies to the integrin beta 2 subunit. A model for the I-like domain.
Huang C; Zang Q; Takagi J; Springer TA
J Biol Chem; 2000 Jul; 275(28):21514-24. PubMed ID: 10779511
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of human coagulation factor VIII by monoclonal antibodies. Mapping of functional epitopes with the use of recombinant factor VIII fragments.
Leyte A; Mertens K; Distel B; Evers RF; De Keyzer-Nellen MJ; Groenen-Van Dooren MM; De Bruin J; Pannekoek H; Van Mourik JA; Verbeet MP
Biochem J; 1989 Oct; 263(1):187-94. PubMed ID: 2481438
[TBL] [Abstract][Full Text] [Related]
20. A factor VIII neutralizing monoclonal antibody and a human inhibitor alloantibody recognizing epitopes in the C2 domain inhibit factor VIII binding to von Willebrand factor and to phosphatidylserine.
Shima M; Scandella D; Yoshioka A; Nakai H; Tanaka I; Kamisue S; Terada S; Fukui H
Thromb Haemost; 1993 Mar; 69(3):240-6. PubMed ID: 7682339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
